Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

Sandro Pignata,Gabriella Ferrandina,Giovanna Scarfone,Paolo Scollo,Franco Odicino,Gennaro Cormio,Dionyssios Katsaros,Antonella Villa,Liliana Mereu,Fabio Ghezzi,Luigi Manzione,Rossella Lauria,Enrico Breda,Desiderio Gueli Alletti,Michela Ballardini,Alessandra Vernaglia Lombardi,Roberto Sorio,Giorgia Mangili,Domenico Priolo,Giovanna Magni,Alessandro Morabito

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

2008

Background Mucinous ovarian carcinoma have a poorer prognosis compared with other histological subtypes. The aim of this study was to evaluate, retrospectively, the activity of chemotherapy in patients with platinum sensitive recurrent mucinous ovarian cancer.

Keywords:

Ovarian cancer
Pathology
Mucinous carcinoma
Carcinoma
Topotecan
Performance status
Mucinous Tumor
Retrospective cohort study
Surgical oncology
Medicine
Oncology
Internal medicine
ovarian carcinoma
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations